NCT02710396 · Interventional trial
Genetic Predictors of Benefit to Pembrolizumab
Overall registry status Terminated
Phase 2
Conditions Carcinoma, Non-Small-Cell Lung
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory